The Pennant Group (PNTG) Stock Price, News & Analysis

Company Overview

The Pennant Group (NASDAQ: PNTG) is a publicly traded holding company that provides specialized services to the asset management industry. Through its operating subsidiaries, the company delivers outsourced fund administration, securities lending, prime brokerage, and capital markets solutions designed to support hedge funds, private equity firms, mutual funds and other institutional investors. By leveraging a combination of technology platforms and industry expertise, The Pennant Group helps clients streamline middle- and back-office processes, enhance operational efficiency and manage regulatory requirements.

Key service offerings include fund accounting and reporting, trade settlement and reconciliation, risk monitoring, securities lending programs and execution support across a range of asset classes. The company’s proxy advisory and compliance services assist sponsors in meeting governance and disclosure standards, while its capital introduction team facilitates connections between emerging managers and potential investors. Together, these capabilities enable managers of both traditional and alternative investment vehicles to focus on portfolio performance rather than administrative burdens.

Headquartered in New York City, The Pennant Group was established in the mid-2010s to consolidate several boutique service providers under a unified platform. It operates primarily in the United States, serving a diverse client base that spans domestic and offshore funds. The company’s leadership team comprises professionals with extensive experience in fund operations, securities markets and regulatory oversight, positioning The Pennant Group to address evolving industry challenges and drive growth through strategic partnerships and service innovation.

Key Stats

• Today's Range: $30.13 to $31.53
• 50-Day Range: $28.90 to $36.90
• 52-Week Range: $21.73 to $37.54
• Volume: 386,680 shs
• Average Volume: 275,477 shs
• Market Capitalization: $1.06 billion
• P/E Ratio: 35.71
• Dividend Yield: N/A
• Price Target: $39.00
• Consensus Rating: Moderate Buy

The Pennant Group Stock Analysis - MarketRank™

The Pennant Group scored higher than 92% of companies evaluated by MarketBeat, and ranked 45th out of 865 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.2 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

The Pennant Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.88, and is based on no strong buy ratings, 7 buy ratings, 1 hold rating, and no sell ratings.

Upside Potential

The Pennant Group has a consensus price target of $39.00, representing about 28.4% upside from its current price of $30.38.

Amount of Analyst Coverage

The Pennant Group has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 17.54%

Earnings Growth

Earnings for The Pennant Group are expected to grow by 17.54% in the coming year, from $1.14 to $1.34 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of The Pennant Group is 35.74, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.58.

Price to Earnings Ratio vs. Sector

The P/E ratio of The Pennant Group is 35.74, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 22.42.

Price to Earnings Growth Ratio

The Pennant Group has a PEG Ratio of 2.15. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

The Pennant Group has a P/B Ratio of 2.81. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.96% of the float of The Pennant Group has been sold short.

Short Interest Ratio / Days to Cover

The Pennant Group has a short interest ratio ("days to cover") of 1.92, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in The Pennant Group has recently decreased by 2.20%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

The Pennant Group does not currently pay a dividend.

Dividend Growth

The Pennant Group does not have a long track record of dividend growth.

News and Social Media

• Score: 3.7 / 5
• News Sentiment: 0.97

News Sentiment

The Pennant Group has a news sentiment score of 0.97. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.78 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for The Pennant Group this week, compared to 3 articles on an average week.

Search Interest

1 people have searched for PNTG on MarketBeat in the last 30 days.

MarketBeat Follows

1 people have added The Pennant Group to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, The Pennant Group insiders have not sold or bought any company stock.

Percentage Held by Insiders

6.90% of the stock of The Pennant Group is held by insiders.

Percentage Held by Institutions

85.88% of the stock of The Pennant Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 5/06/2026
• Today: 6/03/2026
• Next Earnings (Estimated): 8/05/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - OUTP/HM CRE
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:PNTG
• CIK: 1766400
• Web: www.pennantgroup.com
• Phone: 208-506-6100
• Fax: N/A
• Employees: 9,700
• Year Founded: 2010

Price Target and Rating

• Average Price Target for The Pennant Group: $39.00
• High Price Target: $42.00
• Low Price Target: $30.00
• Potential Upside/Downside: +28.9%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.88
• Research Coverage: 8 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.85
• Trailing P/E Ratio: 35.90
• Forward P/E Ratio: 26.55
• P/E Growth: 2.15
• Net Income: $29.58 million
• Net Margins: 2.96%
• Pretax Margin: 4.72%
• Return on Equity: 10.07%
• Return on Assets: 4.23%

Debt

• Debt-to-Equity Ratio: 0.42
• Current Ratio: 1.19
• Quick Ratio: 1.19

Sales & Book Value

• Annual Sales: $947.71 million
• Price / Sales: 1.11
• Cash Flow: $1.21 per share
• Price / Cash Flow: 24.97
• Book Value: $10.82 per share
• Price / Book: 2.80

Miscellaneous

• Outstanding Shares: 34,770,000
• Free Float: 32,369,000
• Market Cap: $1.05 billion
• Optionable: Optionable
• Beta: 1.29